Evidence map›Paper›PMID 40562440›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2025

Ana Paula Santos, Rosana Souza Rodrigues, Erik H J G Aarntzen, Paulo Henrique Rosado de Castro, Cecile Magis-Escurra, Fernanda Carvalho de Queiroz Mello

Abstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. DisseminatedFrontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Paula SantosFederal University of Rio de Janeiro, Thoracic Diseases Institute, Rio de Janeiro, Brazil anapsantos.ip@gmail.com.ORCID https://orcid.org/0000-0001-5226-4372
Rosana Souza RodriguesFederal University of Rio de Janeiro, Clementino Fraga Filho University Hospital, Radiology Department, Rio de Janeiro, Brazil.
Erik H J G AarntzenGroningen University, Department of Nuclear Medicine and Molecular Imaging, Groningen, The Netherlands.
Paulo Henrique Rosado de CastroD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Cecile Magis-EscurraRadboud University Medical Center, Department of Respiratory Diseases-TB Expert Center Dekkerswald, Nijmegen, The Netherlands.
Fernanda Carvalho de Queiroz MelloFederal University of Rio de Janeiro, Thoracic Diseases Institute, Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of positron emission tomography (PET) combined with computed tomography (CT) in the field of inflammatory/infectious diseases heralds an era of personalised disease management using these noninvasive technologies. This nuclear medicine technique can be a useful tool in tuberculosis (TB) for assessing the extent of extrapulmonary disease, evaluating treatment response and identifying patients at higher risk of disease relapse. The fusion of functional imaging provided by PET with the anatomical and morphological details captured by CT has enabled clinicians to better understand the dynamics of the pathophysiology and natural course of

Indexed as

Fluorodeoxyglucose F18LungPositron Emission Tomography Computed TomographyRadiopharmaceuticalsTuberculosis, Lymph NodeTuberculosis, PulmonaryHumansMycobacterium tuberculosisPredictive Value of TestsPrognosisReproducibility of ResultsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID40562440
PMCPMC12220741

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.